Key result
Patients with primary biliary cirrhosis had lower visceral fat diameter compared to healthy controls.
Why the study?
Do patients with primary biliary cirrhosis have different amounts of abdominal adiposity compared to healthy controls?
Case-Control (n=90)
Do patients with primary biliary cirrhosis have different amounts of abdominal adiposity compared to healthy controls?
Answers are grounded in this paper and cite their sources.
Patients with primary biliary cirrhosis have significantly lower amounts of visceral fat compared to healthy controls, which may explain a lower incidence of cardiovascular events despite hyperlipidemia.
BACKGROUND/AIM: Primary biliary cirrhosis (PBC) is a progressive, chronic liver disease with elevated serum lipids, but it is unclear whether hyperlipidemia in PBC patients is associated with atherosclerosis. Metabolic syndrome promotes development of atherosclerotic cardiovascular disease related to abdominal type obesity and insulin resistance. The aim of our study was to assess abdominal adiposity in patients with PBC. METHODS: The study included 40 patients with PBC and 50 healthy controls. Age, sex and anthropometric measurements (weight, height, body mass index and waist circumference) were registered for all patients and controls. We used ultrasonography to measure subcutaneous (SF) and visceral fat (VF) diameter, subcutaneous area (SA) and visceral area (VA), as well as perirenal fat diameter (PF). RESULTS: Values of SF, VF and PF thicknesses in PBC patients were 19.23 +/- 5.85 mm, 10.92 +/- 3.63 mm, and 7.03 +/- 1.82 mm, respectively. In controls these measurements were 22.73 +/- 6.70 mm, 16.84 +/-5.51 mm and 10.50 +/- 2.70 mm respectively. In PBC patients SA and VA were calculated to 983.64 +/- 322.68 mm2 and 403.64 +/- 166.97 mm2 and in controls 1124.89 +/- 366.01 mm2 and 720.57 +/- 272.50 mm2 respectively. Significant difference was found for VF, VA and RF values. CONCLUSIONS: Considering that the amount of visceral fat plays an important role in development of metabolic syndrome and cardiovascular diseases, we concluded that the lower amount of visceral fat in PBC patients could be related to lower incidence of cardiovascular events, despite hyperlipidemia.
No takes yet. Share an insight, caveat, or question.
Alempijević et al. (2011) conducted a case-control in Primary biliary cirrhosis (n=90). Primary biliary cirrhosis vs. Healthy controls was evaluated on Visceral fat diameter (mm). Patients with primary biliary cirrhosis had lower visceral fat diameter compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: